Ivermectin: Pros vs Cons. Dr. Luis Garegnani and Dr. Pierre Kory Debate The Issue

Dr. Luis Garegnani from Argentia wrote an opinion piece on Ivermectin not having enough evidence behind it in BMJ Journals. Dr. Pierre Kory of the FLCCC disagrees. Both doctors debate this issue with Dr. Erin Stair as the moderator.

About Luis Garegnani:Luis Garegnani is a Professor of Research methods and evidence-based medicine at Instituto Universitario del Hospital Italiano de Buenos Aires.He is also a Physical Therapist from Universidad de Buenos Aires (UBA), specializing in Respiratory Critical Care and Mechanical Ventilation. He is a Research Fellow at Instituto Universitario del Hospital Italiano Cochrane Associate Centre since 2018 and currently an Associate Editor for the peer-reviewed BMJ Evidence-Based Medicine Journal.

See Article Written by Dr. Louis Garegnani | https://ebm.bmj.com/content/early/2021/05/26/bmjebm-2021-111678

About Pierre Kory:Founding member of the FLCCC Alliance and co-author of the MATH+ and I-MASK+ Prophylaxis and Treatment Protocols for Covid-19

FLCCC Website | https://covid19criticalcare.com/


Note:  If you need assistance with your subscription or would like to discuss a corporate subscription for more than 10 employees please contact us or use the chat (bottom right).

$5 / Month
Individuals at home that are reading our content for personal health care or other non-professional reasons.
Like a Starbucks a month
Personal - Single Payment
$50 for 1 Year
Individuals - reading for personal reasons who prefer to pay for one year in advance with no recurring billing.
18% discount to monthly
$12 / Month
Professionals from the healthcare industry who are subscribing on behalf of their company for work reasons.
Way better than coffee